Skip to main content

Clearside Biomedical, Inc - Phase I/II Clinical Study

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Feb 12, 2013
Award amount: 
$250,000
Organization name: 
Clearside Biomedical, Inc
Principal Investigator: 
Deignan, Charles A.
Grant program category: 
Business Financing
Grant program name: 
Strategic Growth Loan
Region: 
Research Triangle

Clearside Biomedical is an start-up ophthalmic company developing and eventually commercializing targeted therapeutics for the treatment of sight threatening diseases using a proprietary disruptive technology. The company is requesting a strategic growth load to help subsidize a Phase I/II clinical study. The study will be managed by North Carolina based employees and vendors from NC will be utilized in conducting the study.

Fiscal year: 
2013